Microenvironment-evoked cell lineage conversion: Shifting the focus from internal reprogramming to external forcing

Ageing Research Reviews
Ji LinWei-dong Han

Abstract

Seeking possible ways to create replacement cells for the faded ones with deficits in functionality or quantity inspires comprehensive needs for cell lineage conversion. To fulfill this promise, reprogramming and microenvironment direction have been used to manipulate abundant cell fates. We briefly describe the evolution and fundamental insights of these two major strategies applied for lineage specification, comment generally on their current limitations, and analyze the orchestral interplay between them. We also present several future directions and discuss the potential clinical uses. Based on the relatively slight safety and technical issues, we conclude that microenvironment-evoked cell lineage conversion, instead of reprogramming, will be the shifting focus in regenerative medicine.

References

Feb 1, 1991·Differentiation; Research in Biological Diversity·C L MummeryA H Piersma
Aug 1, 1989·Trends in Genetics : TIG·H M Blau
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H WeintraubA D Miller
Mar 1, 1969·Journal of Theoretical Biology·S A Kauffman
Oct 29, 1993·Science·T M LambR M Harland
Feb 1, 1997·Journal of Cellular Biochemistry·N JaiswalS P Bruder
Dec 6, 1997·Developmental Dynamics : an Official Publication of the American Association of Anatomists·A AraiJ Toyama
Jun 26, 1998·Development Genes and Evolution·L MarchantR Mayor
Dec 4, 2001·Genes & Development·P W Ingham, A P McMahon
Mar 5, 2002·Nature·Konrad Hochedlinger, Rudolf Jaenisch
Aug 15, 2002·Cell·Hynek WichterleThomas M Jessell
Dec 6, 2002·Journal of the American Chemical Society·Xu WuPeter G Schultz
Apr 2, 2003·Circulation·Tomosaburo TakahashiRichard T Lee
Jun 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sheng DingPeter G Schultz
Jun 18, 2003·Development·Tracy J Wright, Suzanne L Mansour
Jun 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·J B Gurdon, J A Byrne
May 11, 2004·Nature Cell Biology·Yoon-Young JangSaul J Sharkis
Jul 2, 2004·Nature Biotechnology·Sheng Ding, Peter G Schultz
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anselme L PerrierLorenz Studer
Feb 11, 2005·Nature·Karl-Ludwig LaugwitzKenneth R Chien
Aug 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Hanako IkedaYoshiki Sasai
Aug 6, 2005·Molecular and Cellular Neurosciences·Pavel ItsyksonBenjamin E Reubinoff
Nov 1, 2005·Nature Biotechnology·Kevin A D'AmourEmmanuel E Baetge
Jan 26, 2006·Stem Cells and Development·Chen XiongYuqing E Chen
Aug 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Deepak A LambaThomas A Reh
Oct 21, 2006·Nature Biotechnology·Kevin A D'AmourEmmanuel E Baetge
Dec 2, 2006·Nature Reviews. Drug Discovery·Lee L Rubin, Frederic J de Sauvage
Jun 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Shuibing ChenPeter G Schultz
Nov 22, 2007·Science·Junying YuJames A Thomson
Sep 27, 2008·Science·Matthias StadtfeldKonrad Hochedlinger
Oct 11, 2008·Science·Keisuke OkitaShinya Yamanaka
Oct 14, 2008·Nature Biotechnology·Danwei HuangfuDouglas A Melton
Oct 23, 2008·Cell Stem Cell·Qiao Zhou, Douglas A Melton

❮ Previous
Next ❯

Citations

Aug 14, 2013·BMC Systems Biology·Walter de BackLutz Brusch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Nature Cell Biology
Ignacio Sancho-MartinezJuan Carlos Izpisua Belmonte
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
Niels J Dingemanse, Max Wolf
© 2021 Meta ULC. All rights reserved